2024-10-23 05:47:56
ASCO 2022 | Ascentage Pharma Releases for the First Time Results of its FAK/ALK/ROS1 inhibitor APG-2449 Demonstrating Safety and Efficacy in Patients with Advanced NSCLC
Corporate/ 2023-07-24
ASCO 2022 | Ascentage Pharma Releases fo...

SUZHOU,China,and ROCKVILLE,MD,June 8,2022--Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in developing novel therapi...

ASCO 2022 | Ascentage Pharma Releases Updated Data Demonstrating Lisaftoclax's (APG-2575) Therapeutic Potential in Patients with R/R CLL/SLL
Corporate/ 2023-07-24
ASCO 2022 | Ascentage Pharma Releases Up...

SUZHOU,China and ROCKVILLE,Md.,June 8,2022-- Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in developing novel thera...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release